<?xml version="1.0"?><rss version="2.0">
 <channel>
  <title>StreetInsider.com News Articles</title>
  <link>http://www.streetinsider.com</link>
  <description>Latest StreetInsider.com News Articles</description>
  <language>en-us</language>
  <copyright>Copyright 2024, StreetInsider.com</copyright>
  <managingEditor>rss@streetinsider.com (SI RSS)</managingEditor>
  <webMaster>rss@streetinsider.com (SI RSS)</webMaster>
  <lastBuildDate>Mon, 26 Feb 2024 13:22:22 -0400</lastBuildDate>
  <docs>http://blogs.law.harvard.edu/tech/rss</docs>
  <image>
   <url>http://www.streetinsider.com/images/rss_logo.gif</url>
   <title>StreetInsider.com News Articles</title>
   <link>http://www.streetinsider.com</link>
   <width>143</width>
   <height>28</height>
  </image>
  <skipHours>
   <hour>0</hour>
   <hour>1</hour>
   <hour>2</hour>
   <hour>3</hour>
   <hour>21</hour>
   <hour>22</hour>
   <hour>23</hour>
  </skipHours>
  <skipDays>
   <day>Saturday</day>
   <day>Sunday</day>
  </skipDays>
  <item>
   <title>APRINOIA Therapeutics (APRI) Announces 2M Share IPO at $10-$14/sh</title>
   <link>http://www.streetinsider.com/IPOs/APRINOIA+Therapeutics+%28APRI%29+Announces+2M+Share+IPO+at+%2410-%2414sh/22832216.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/IPOs/APRINOIA+Therapeutics+%28APRI%29+Announces+2M+Share+IPO+at+%2410-%2414sh/22832216.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/IPOs/APRINOIA+Therapeutics+%28APRI%29+Announces+2M+Share+IPO+at+%2410-%2414sh/22832216.html</guid>
   <pubDate>Mon, 26 Feb 2024 13:22:22 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">APRI</category>
   	  </item>
  <item>
   <title>APRINOIA Therapeutics (APRI) Announces 2M Share IPO at $10-$14/sh</title>
   <link>http://www.streetinsider.com/Corporate+News/APRINOIA+Therapeutics+%28APRI%29+Announces+2M+Share+IPO+at+%2410-%2414sh/22832216.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/APRINOIA+Therapeutics+%28APRI%29+Announces+2M+Share+IPO+at+%2410-%2414sh/22832216.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Corporate+News/APRINOIA+Therapeutics+%28APRI%29+Announces+2M+Share+IPO+at+%2410-%2414sh/22832216.html</guid>
   <pubDate>Mon, 26 Feb 2024 13:22:22 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">APRI</category>
   	  </item>
  <item>
   <title>APRINOIA Therapeutics (APRI) Announces Proposed IPO</title>
   <link>http://www.streetinsider.com/IPOs/APRINOIA+Therapeutics+%28APRI%29+Announces+Proposed+IPO/22677906.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/IPOs/APRINOIA+Therapeutics+%28APRI%29+Announces+Proposed+IPO/22677906.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/IPOs/APRINOIA+Therapeutics+%28APRI%29+Announces+Proposed+IPO/22677906.html</guid>
   <pubDate>Fri, 26 Jan 2024 06:06:59 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">APRI</category>
   	  </item>
  <item>
   <title>APRINOIA Therapeutics (APRI) Announces Proposed IPO</title>
   <link>http://www.streetinsider.com/Corporate+News/APRINOIA+Therapeutics+%28APRI%29+Announces+Proposed+IPO/22677906.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/APRINOIA+Therapeutics+%28APRI%29+Announces+Proposed+IPO/22677906.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Corporate+News/APRINOIA+Therapeutics+%28APRI%29+Announces+Proposed+IPO/22677906.html</guid>
   <pubDate>Fri, 26 Jan 2024 06:06:59 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">APRI</category>
   	  </item>
  <item>
   <title>Form  8-K        APRICUS BIOSCIENCES,      For: Jan 24</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++APRICUS+BIOSCIENCES%2C++++++For%3A+Jan+24/15035113.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++APRICUS+BIOSCIENCES%2C++++++For%3A+Jan+24/15035113.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++APRICUS+BIOSCIENCES%2C++++++For%3A+Jan+24/15035113.html</guid>
   <pubDate>Thu, 24 Jan 2019 08:07:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">APRI</category>
   	  </item>
  <item>
   <title>Form  8-K        APRICUS BIOSCIENCES,      For: Jan 23</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++APRICUS+BIOSCIENCES%2C++++++For%3A+Jan+23/15035100.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++APRICUS+BIOSCIENCES%2C++++++For%3A+Jan+23/15035100.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++APRICUS+BIOSCIENCES%2C++++++For%3A+Jan+23/15035100.html</guid>
   <pubDate>Thu, 24 Jan 2019 08:06:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">APRI</category>
   	  </item>
  <item>
   <title>Seelos Therapeutics, Inc. Announces Successful Completion of its Merger with Apricus Biosciences, Inc. to Advance Late-Stage Pipeline of Products for Central Nervous System (CNS) Disorders</title>
   <link>http://www.streetinsider.com/Press+Releases/Seelos+Therapeutics%2C+Inc.+Announces+Successful+Completion+of+its+Merger+with+Apricus+Biosciences%2C+Inc.+to+Advance+Late-Stage+Pipeline+of+Products+for+Central+Nervous+System+%28CNS%29+Disorders/15035061.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Seelos+Therapeutics%2C+Inc.+Announces+Successful+Completion+of+its+Merger+with+Apricus+Biosciences%2C+Inc.+to+Advance+Late-Stage+Pipeline+of+Products+for+Central+Nervous+System+%28CNS%29+Disorders/15035061.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Seelos+Therapeutics%2C+Inc.+Announces+Successful+Completion+of+its+Merger+with+Apricus+Biosciences%2C+Inc.+to+Advance+Late-Stage+Pipeline+of+Products+for+Central+Nervous+System+%28CNS%29+Disorders/15035061.html</guid>
   <pubDate>Thu, 24 Jan 2019 08:01:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.02846591</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.33378433</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">APRI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LGND</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SEEL</category>
   	  </item>
  <item>
   <title>Seelos Therapeutics, Inc. Announces Successful Completion of its Merger with Apricus Biosciences, Inc. to Advance Late-Stage Pipeline of Products for Central Nervous System (CNS) Disorders</title>
   <link>http://www.streetinsider.com/Press+Releases/Seelos+Therapeutics%2C+Inc.+Announces+Successful+Completion+of+its+Merger+with+Apricus+Biosciences%2C+Inc.+to+Advance+Late-Stage+Pipeline+of+Products+for+Central+Nervous+System+%28CNS%29+Disorders/15035061.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Seelos+Therapeutics%2C+Inc.+Announces+Successful+Completion+of+its+Merger+with+Apricus+Biosciences%2C+Inc.+to+Advance+Late-Stage+Pipeline+of+Products+for+Central+Nervous+System+%28CNS%29+Disorders/15035061.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Seelos+Therapeutics%2C+Inc.+Announces+Successful+Completion+of+its+Merger+with+Apricus+Biosciences%2C+Inc.+to+Advance+Late-Stage+Pipeline+of+Products+for+Central+Nervous+System+%28CNS%29+Disorders/15035061.html</guid>
   <pubDate>Thu, 24 Jan 2019 08:01:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.02846591</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.33378433</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">APRI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LGND</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SEEL</category>
   	  </item>
  <item>
   <title>Seelos Therapeutics, Inc. Announces Successful Completion of its Merger with Apricus Biosciences, Inc. to Advance Late-Stage Pipeline of Products for Central Nervous System (CNS) Disorders</title>
   <link>http://www.streetinsider.com/Press+Releases/Seelos+Therapeutics%2C+Inc.+Announces+Successful+Completion+of+its+Merger+with+Apricus+Biosciences%2C+Inc.+to+Advance+Late-Stage+Pipeline+of+Products+for+Central+Nervous+System+%28CNS%29+Disorders/15035061.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Seelos+Therapeutics%2C+Inc.+Announces+Successful+Completion+of+its+Merger+with+Apricus+Biosciences%2C+Inc.+to+Advance+Late-Stage+Pipeline+of+Products+for+Central+Nervous+System+%28CNS%29+Disorders/15035061.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Seelos+Therapeutics%2C+Inc.+Announces+Successful+Completion+of+its+Merger+with+Apricus+Biosciences%2C+Inc.+to+Advance+Late-Stage+Pipeline+of+Products+for+Central+Nervous+System+%28CNS%29+Disorders/15035061.html</guid>
   <pubDate>Thu, 24 Jan 2019 08:01:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.02846591</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.33378433</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">APRI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LGND</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SEEL</category>
   	  </item>
  <item>
   <title>Seelos Therapeutics, Inc. Announces Successful Completion of its Merger with Apricus Biosciences, Inc. to Advance Late-Stage Pipeline of Products for Central Nervous System (CNS) Disorders</title>
   <link>http://www.streetinsider.com/Press+Releases/Seelos+Therapeutics%2C+Inc.+Announces+Successful+Completion+of+its+Merger+with+Apricus+Biosciences%2C+Inc.+to+Advance+Late-Stage+Pipeline+of+Products+for+Central+Nervous+System+%28CNS%29+Disorders/15035061.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Seelos+Therapeutics%2C+Inc.+Announces+Successful+Completion+of+its+Merger+with+Apricus+Biosciences%2C+Inc.+to+Advance+Late-Stage+Pipeline+of+Products+for+Central+Nervous+System+%28CNS%29+Disorders/15035061.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Seelos+Therapeutics%2C+Inc.+Announces+Successful+Completion+of+its+Merger+with+Apricus+Biosciences%2C+Inc.+to+Advance+Late-Stage+Pipeline+of+Products+for+Central+Nervous+System+%28CNS%29+Disorders/15035061.html</guid>
   <pubDate>Thu, 24 Jan 2019 08:01:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.02846591</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.33378433</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">APRI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LGND</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SEEL</category>
   	  </item>
  <item>
   <title>Seelos Therapeutics, Inc. Announces Successful Completion of its Merger with Apricus Biosciences, Inc. to Advance Late-Stage Pipeline of Products for Central Nervous System (CNS) Disorders</title>
   <link>http://www.streetinsider.com/Press+Releases/Seelos+Therapeutics%2C+Inc.+Announces+Successful+Completion+of+its+Merger+with+Apricus+Biosciences%2C+Inc.+to+Advance+Late-Stage+Pipeline+of+Products+for+Central+Nervous+System+%28CNS%29+Disorders/15035061.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Seelos+Therapeutics%2C+Inc.+Announces+Successful+Completion+of+its+Merger+with+Apricus+Biosciences%2C+Inc.+to+Advance+Late-Stage+Pipeline+of+Products+for+Central+Nervous+System+%28CNS%29+Disorders/15035061.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Seelos+Therapeutics%2C+Inc.+Announces+Successful+Completion+of+its+Merger+with+Apricus+Biosciences%2C+Inc.+to+Advance+Late-Stage+Pipeline+of+Products+for+Central+Nervous+System+%28CNS%29+Disorders/15035061.html</guid>
   <pubDate>Thu, 24 Jan 2019 08:01:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.02846591</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.33378433</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">APRI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LGND</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SEEL</category>
   	  </item>
  <item>
   <title>Seelos Therapeutics, Inc. Announces Successful Completion of its Merger with Apricus Biosciences, Inc. to Advance Late-Stage Pipeline of Products for Central Nervous System (CNS) Disorders</title>
   <link>http://www.streetinsider.com/Press+Releases/Seelos+Therapeutics%2C+Inc.+Announces+Successful+Completion+of+its+Merger+with+Apricus+Biosciences%2C+Inc.+to+Advance+Late-Stage+Pipeline+of+Products+for+Central+Nervous+System+%28CNS%29+Disorders/15035061.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Seelos+Therapeutics%2C+Inc.+Announces+Successful+Completion+of+its+Merger+with+Apricus+Biosciences%2C+Inc.+to+Advance+Late-Stage+Pipeline+of+Products+for+Central+Nervous+System+%28CNS%29+Disorders/15035061.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Seelos+Therapeutics%2C+Inc.+Announces+Successful+Completion+of+its+Merger+with+Apricus+Biosciences%2C+Inc.+to+Advance+Late-Stage+Pipeline+of+Products+for+Central+Nervous+System+%28CNS%29+Disorders/15035061.html</guid>
   <pubDate>Thu, 24 Jan 2019 08:01:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.02846591</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.33378433</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">APRI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LGND</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SEEL</category>
   	  </item>
  <item>
   <title>Seelos Therapeutics, Inc. Announces Successful Completion of its Merger with Apricus Biosciences, Inc. to Advance Late-Stage Pipeline of Products for Central Nervous System (CNS) Disorders</title>
   <link>http://www.streetinsider.com/Press+Releases/Seelos+Therapeutics%2C+Inc.+Announces+Successful+Completion+of+its+Merger+with+Apricus+Biosciences%2C+Inc.+to+Advance+Late-Stage+Pipeline+of+Products+for+Central+Nervous+System+%28CNS%29+Disorders/15035054.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Seelos+Therapeutics%2C+Inc.+Announces+Successful+Completion+of+its+Merger+with+Apricus+Biosciences%2C+Inc.+to+Advance+Late-Stage+Pipeline+of+Products+for+Central+Nervous+System+%28CNS%29+Disorders/15035054.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Seelos+Therapeutics%2C+Inc.+Announces+Successful+Completion+of+its+Merger+with+Apricus+Biosciences%2C+Inc.+to+Advance+Late-Stage+Pipeline+of+Products+for+Central+Nervous+System+%28CNS%29+Disorders/15035054.html</guid>
   <pubDate>Thu, 24 Jan 2019 08:01:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">APRI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LGND</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SEEL</category>
   	  </item>
  <item>
   <title>Seelos Therapeutics, Inc. Announces Successful Completion of its Merger with Apricus Biosciences, Inc. to Advance Late-Stage Pipeline of Products for Central Nervous System (CNS) Disorders</title>
   <link>http://www.streetinsider.com/Press+Releases/Seelos+Therapeutics%2C+Inc.+Announces+Successful+Completion+of+its+Merger+with+Apricus+Biosciences%2C+Inc.+to+Advance+Late-Stage+Pipeline+of+Products+for+Central+Nervous+System+%28CNS%29+Disorders/15035054.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Seelos+Therapeutics%2C+Inc.+Announces+Successful+Completion+of+its+Merger+with+Apricus+Biosciences%2C+Inc.+to+Advance+Late-Stage+Pipeline+of+Products+for+Central+Nervous+System+%28CNS%29+Disorders/15035054.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Seelos+Therapeutics%2C+Inc.+Announces+Successful+Completion+of+its+Merger+with+Apricus+Biosciences%2C+Inc.+to+Advance+Late-Stage+Pipeline+of+Products+for+Central+Nervous+System+%28CNS%29+Disorders/15035054.html</guid>
   <pubDate>Thu, 24 Jan 2019 08:01:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">APRI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LGND</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SEEL</category>
   	  </item>
  <item>
   <title>Seelos Therapeutics, Inc. Announces Successful Completion of its Merger with Apricus Biosciences, Inc. to Advance Late-Stage Pipeline of Products for Central Nervous System (CNS) Disorders</title>
   <link>http://www.streetinsider.com/Press+Releases/Seelos+Therapeutics%2C+Inc.+Announces+Successful+Completion+of+its+Merger+with+Apricus+Biosciences%2C+Inc.+to+Advance+Late-Stage+Pipeline+of+Products+for+Central+Nervous+System+%28CNS%29+Disorders/15035054.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Seelos+Therapeutics%2C+Inc.+Announces+Successful+Completion+of+its+Merger+with+Apricus+Biosciences%2C+Inc.+to+Advance+Late-Stage+Pipeline+of+Products+for+Central+Nervous+System+%28CNS%29+Disorders/15035054.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Seelos+Therapeutics%2C+Inc.+Announces+Successful+Completion+of+its+Merger+with+Apricus+Biosciences%2C+Inc.+to+Advance+Late-Stage+Pipeline+of+Products+for+Central+Nervous+System+%28CNS%29+Disorders/15035054.html</guid>
   <pubDate>Thu, 24 Jan 2019 08:01:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">APRI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LGND</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SEEL</category>
   	  </item>
  <item>
   <title>Form  4          APRICUS BIOSCIENCES,      For: Jan 23  Filed by: Pascoe Richard W</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++APRICUS+BIOSCIENCES%2C++++++For%3A+Jan+23++Filed+by%3A+Pascoe+Richard+W/15034410.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++4++++++++++APRICUS+BIOSCIENCES%2C++++++For%3A+Jan+23++Filed+by%3A+Pascoe+Richard+W/15034410.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++APRICUS+BIOSCIENCES%2C++++++For%3A+Jan+23++Filed+by%3A+Pascoe+Richard+W/15034410.html</guid>
   <pubDate>Thu, 24 Jan 2019 06:06:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">APRI</category>
   	  </item>
  <item>
   <title>Form  4          APRICUS BIOSCIENCES,      For: Jan 23  Filed by: Morton Neil</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++APRICUS+BIOSCIENCES%2C++++++For%3A+Jan+23++Filed+by%3A+Morton+Neil/15034408.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++4++++++++++APRICUS+BIOSCIENCES%2C++++++For%3A+Jan+23++Filed+by%3A+Morton+Neil/15034408.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++APRICUS+BIOSCIENCES%2C++++++For%3A+Jan+23++Filed+by%3A+Morton+Neil/15034408.html</guid>
   <pubDate>Thu, 24 Jan 2019 06:06:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">APRI</category>
   	  </item>
  <item>
   <title>Form  8-K        APRICUS BIOSCIENCES,      For: Jan 16</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++APRICUS+BIOSCIENCES%2C++++++For%3A+Jan+16/15014576.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++APRICUS+BIOSCIENCES%2C++++++For%3A+Jan+16/15014576.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++APRICUS+BIOSCIENCES%2C++++++For%3A+Jan+16/15014576.html</guid>
   <pubDate>Wed, 16 Jan 2019 17:31:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">APRI</category>
   	  </item>
  <item>
   <title>Form  425        APRICUS BIOSCIENCES,                   Filed by: APRICUS BIOSCIENCES, INC.</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++425++++++++APRICUS+BIOSCIENCES%2C+++++++++++++++++++Filed+by%3A+APRICUS+BIOSCIENCES%2C+INC./15014556.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++425++++++++APRICUS+BIOSCIENCES%2C+++++++++++++++++++Filed+by%3A+APRICUS+BIOSCIENCES%2C+INC./15014556.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++425++++++++APRICUS+BIOSCIENCES%2C+++++++++++++++++++Filed+by%3A+APRICUS+BIOSCIENCES%2C+INC./15014556.html</guid>
   <pubDate>Wed, 16 Jan 2019 17:29:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">APRI</category>
   	  </item>
  <item>
   <title>Apricus Biosciences (APRI) Stockholders Approve Proposed Merger with Seelos Therapeutics</title>
   <link>http://www.streetinsider.com/Corporate+News/Apricus+Biosciences+%28APRI%29+Stockholders+Approve+Proposed+Merger+with+Seelos+Therapeutics/15006766.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Apricus+Biosciences+%28APRI%29+Stockholders+Approve+Proposed+Merger+with+Seelos+Therapeutics/15006766.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Corporate+News/Apricus+Biosciences+%28APRI%29+Stockholders+Approve+Proposed+Merger+with+Seelos+Therapeutics/15006766.html</guid>
   <pubDate>Tue, 15 Jan 2019 07:10:55 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">APRI</category>
   	  </item>
  <item>
   <title>Apricus Biosciences (APRI) Stockholders Approve Proposed Merger with Seelos Therapeutics</title>
   <link>http://www.streetinsider.com/Mergers+and+Acquisitions/Apricus+Biosciences+%28APRI%29+Stockholders+Approve+Proposed+Merger+with+Seelos+Therapeutics/15006766.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Mergers+and+Acquisitions/Apricus+Biosciences+%28APRI%29+Stockholders+Approve+Proposed+Merger+with+Seelos+Therapeutics/15006766.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Mergers+and+Acquisitions/Apricus+Biosciences+%28APRI%29+Stockholders+Approve+Proposed+Merger+with+Seelos+Therapeutics/15006766.html</guid>
   <pubDate>Tue, 15 Jan 2019 07:10:55 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">APRI</category>
   	  </item>
  <item>
   <title>Apricus Biosciences Stockholders Approve Proposed Merger with Seelos Therapeutics, Inc.</title>
   <link>http://www.streetinsider.com/Press+Releases/Apricus+Biosciences+Stockholders+Approve+Proposed+Merger+with+Seelos+Therapeutics%2C+Inc./15006706.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Apricus+Biosciences+Stockholders+Approve+Proposed+Merger+with+Seelos+Therapeutics%2C+Inc./15006706.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Apricus+Biosciences+Stockholders+Approve+Proposed+Merger+with+Seelos+Therapeutics%2C+Inc./15006706.html</guid>
   <pubDate>Tue, 15 Jan 2019 07:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.09399774</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.33378433</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">APRI</category>
   	  </item>
  <item>
   <title>Apricus Biosciences Stockholders Approve Proposed Merger with Seelos Therapeutics, Inc.</title>
   <link>http://www.streetinsider.com/Press+Releases/Apricus+Biosciences+Stockholders+Approve+Proposed+Merger+with+Seelos+Therapeutics%2C+Inc./15006706.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Apricus+Biosciences+Stockholders+Approve+Proposed+Merger+with+Seelos+Therapeutics%2C+Inc./15006706.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Apricus+Biosciences+Stockholders+Approve+Proposed+Merger+with+Seelos+Therapeutics%2C+Inc./15006706.html</guid>
   <pubDate>Tue, 15 Jan 2019 07:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.09399774</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.33378433</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">APRI</category>
   	  </item>
  <item>
   <title>Apricus Biosciences Stockholders Approve Proposed Merger with Seelos Therapeutics, Inc.</title>
   <link>http://www.streetinsider.com/Press+Releases/Apricus+Biosciences+Stockholders+Approve+Proposed+Merger+with+Seelos+Therapeutics%2C+Inc./15006706.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Apricus+Biosciences+Stockholders+Approve+Proposed+Merger+with+Seelos+Therapeutics%2C+Inc./15006706.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Apricus+Biosciences+Stockholders+Approve+Proposed+Merger+with+Seelos+Therapeutics%2C+Inc./15006706.html</guid>
   <pubDate>Tue, 15 Jan 2019 07:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.09399774</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.33378433</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">APRI</category>
   	  </item>
 </channel>
</rss>
